Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Do a little research on Rainbow Capital Corporation (RBCC) and the backgrounds of the individuals who are associated with it. Makes you wonder why Amarantus Bioscience is partnering with them.

We were expecting the data from the MANF study to be released on 12/22. Why did the company delay its release for almost three weeks? Possibly the news is not as good as expected but management wanted to capitalize on the upward momentum by delaying bad news so that more shares could be moved at a higher price? How many more notes have been issued that allow the debt holders to convert at a 50-55% discount to the market? Remember shares issued under those note conversions don't have to be listed in an immediate filing.

To me the smart move by the company would have been to have stated that the MANF study data was positive and that the commercial potential of the MANF technology would be the key focus of the presentation in January. When that didn't happen I decided 300% profit for a week was sufficient return on my investment. Obviously anyone that wants similar returns can buy AMBS today and hopefully sell above .22.

I've been wrong before and sold too early.

I'll also probably buy some shares on the next bear raid when it drops 40% during a trading session.

It's the land of penny stocks. Stocks go up and they go down.

"Merry Christmas" to all.

p.s. Over the last two days I've received almost 30 private messages. I am limited to 15 posts a day on the board and have no ability to respond to private messages. I will say that the delay in releasing the MANF study data may not be as significant as I think it is but the we'll know soon enough.